- Home
- A-Z Publications
- Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents)
- Previous Issues
- Volume 22, Issue 15, 2022
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents) - Volume 22, Issue 15, 2022
Volume 22, Issue 15, 2022
-
-
New Frontiers in the Discovery and Development of PROTACs
More LessProteolysis targeting chimeras (PROTACs) are an emerging class of targeted protein degraders that coopt the intracellular degradation machinery to selectively deplete their respective targets. PROTACs act as bifunctional degraders that comprise ubiquitin E3 ligase- and target-binding moieties connected by chemical linkers with appropriate physicochemical properties. Through this bivalent structure, PROTACs induce the degrad Read More
-
-
-
Switch Pocket Kinase: An Emerging Therapeutic Target for the Design of Anticancer Agents
Authors: Charanjit Kaur, Bhargavi Sharma and Kunal NepaliProtein kinases are amongst the most focused enzymes in the current century to design, synthesize and formulate drugs that ought to be effective in the treatment of various disordered and diseased states involving either overexpression or deficiency situations. The ATP pocket on the kinases is the active binding site for most of the kinase inhibitors. However, the kinase mutations prevent the binding of kinase inhibitors to the AT Read More
-
-
-
Liposomal Drug Delivery and Its Potential Impact on Cancer Research
Authors: Sankha Bhattacharya, Dnyanesh Saindane and Bhupendra G. PrajapatiLiposomes are one of the most versatile drug carriers due to their functional properties, such as higher biocompatibility, the ability to encapsulate hydrophilic and hydrophobic products, and higher biodegradability. Liposomes are a better and more significant nanocarrier for cancer therapy. The key to developing a better cancer-targeted nanocarrier is the development of targeted liposomes using various approaches. Severa Read More
-
-
-
Metal-based Complexes as Potential Anti-cancer Agents
Authors: Sabyasachi Banerjee and Subhasis BanerjeeMetal based therapy is no new in biomedical research. In early days, the biggest limitation was the inequality among therapeutical and toxicological dosages. Ever since, Barnett Rosenberg discovered cisplatin, a new era has begun to treat cancer with metal complexes. Platinum complexes such as oxaliplatin, cisplatin, and carboplatin, seem to be the foundation of metal/s-based components to challenge malignancies. With advan Read More
-
-
-
Advances in the Novel Nanotechnology for Targeted Tumor Therapy by Transdermal Drug Delivery
Authors: Yuchen Wang and Guan JiangDespite modern medicine advances greatly, cancer remains a serious challenge to world health for which effective methods of treatment have hardly been developed yet. However, throughout recent years, rapid-developing nanotechnology has provided a new outlook on cancer therapy by transdermal drug delivery. By disrupting the stratum corneum, drugs are delivered through the skin and navigated to the tumor site by Read More
-
-
-
Application of Selenium Nanoparticles in Localized Drug Targeting for Cancer Therapy
Authors: Dipak Nath, Loveleen Kaur, Harvinder S. Sohal, Dharambeer Singh Malhi, Sonali Garg and Deepa ThakurBackground: Selenium nanoparticles (SeNPs) have gained a place in the biomedical field; they serve as chemotherapeutic agents for targeted drug delivery due to their capacity to exert distinct mechanisms of action on cancer and normal cells. The principle behind these mechanisms is the generation of reactive oxygen species (ROS), which accelerates apoptosis via the dysfunction of various pathways. SeNPs, when used in Read More
-
-
-
Drug Repurposing Strategies for Non-cancer to Cancer Therapeutics
Authors: Shipra Singhal, Priyal Maheshwari, Praveen T. Krishnamurthy and Vaishali M. PatilGlobal efforts invested in the prevention and treatment of cancer need to be repositioned to develop safe, effective, and economic anticancer therapeutics by adopting rational approaches of drug discovery. Drug repurposing is one of the established approaches to reposition old, clinically approved off-patent noncancer drugs with known targets into newer indications. The literature review suggests a key role of drug repur Read More
-
-
-
The Impact of Bioactive Compounds Derived from Marine Fish on Cancer
Authors: S. Mirunalini and V.L. MaruthanilaCancer persists as the world's leading cause of mortality, thereby making it a compelling condition to research and potentially develop prevention options. Anticancer therapies such as chemotherapy, surgery and radiation therapy are becoming highly futile and tend to have achieved a clinical deficit due to massive side effects, toxicities, and limited specificity. Anticancer agents from natural sources, such as aquatic fishes, terr Read More
-
-
-
Effects of Berberine on Leukemia with a Focus on Its Molecular Targets
Leukemia is common among both women and men worldwide. Besides the fact that finding new treatment methods may enhance the life quality of patients, there are several problems that we face today in treating leukemia patients, such as drugs’ side effects and acquired resistance to chemotherapeutic drugs. Berberine is a bioactive alkaloid found in herbal plants (e.g., Rhizoma coptidis and Cortex phellodendri) and ex Read More
-
-
-
A Therapeutic Journey of Pyridine-based Heterocyclic Compounds as Potent Anticancer Agents: A Review (From 2017 to 2021)
Pyridine derivatives are the most common and significant heterocyclic compounds, which show their fundamental characteristics to various pharmaceutical agents and natural products. Pyridine derivatives possess several pharmacological properties and a broad degree of structural diversity that is most valuable for exploring novel therapeutic agents. These compounds have an extensive range of biological activities Read More
-
-
-
Antimutagenic and Antiproliferative Activity of the Coccoloba uvifera L. Extract Loaded in Nanofibers of Gelatin/Agave Fructans Elaborated by Electrospinning
Background: The Coccoloba uvifera L. species is currently considered an important source of compounds of high biological value such as lupeol. This is related to different and important biological activities to human health. Objective: The objective of this study was to encapsulate the C. uvifera extract in nanofibers made with the biopolymers gelatin (G)/high-grade polymerization agave fructans (HDPAF) in the proportion Read More
-
-
-
Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9 via Targeting MIF
Authors: Yao Duan, Xiaojin Huang, Bo Qiao, Rui Ma and Jialin LiBackground: Oral squamous cell carcinoma (OSCC) is a rampant cancer type in head and neck cancers with a poor prognosis and a high recurrence rate. Eugenol shows an anticancer effect in a variety of cancers, but it has been rarely studied in oral squamous cell carcinoma (OSCC). Objective: The purpose of this study was to explore the role of Eugenol in OSCC and the underlying mechanism. Methods: After different Read More
-
Volumes & issues
-
Volume 25 (2025)
-
Volume 24 (2024)
-
Volume 23 (2023)
-
Volume 22 (2022)
-
Volume 21 (2021)
-
Volume 20 (2020)
-
Volume 19 (2019)
-
Volume 18 (2018)
-
Volume 17 (2017)
-
Volume 16 (2016)
-
Volume 15 (2015)
-
Volume 14 (2014)
-
Volume 13 (2013)
-
Volume 12 (2012)
-
Volume 11 (2011)
-
Volume 10 (2010)
-
Volume 9 (2009)
-
Volume 8 (2008)
-
Volume 7 (2007)
-
Volume 6 (2006)
Most Read This Month
Article
content/journals/acamc
Journal
10
5
false
en
